| Catalog No. | Size | Price (USD) |
| 106737-T08-50 | 50 µL | $147.96 |
| 106737-T08-100 | 100 µL | $251.64 |
| 106737-T08-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-ADAMTS4 Antibody, Rabbit Polyclonal |
| Validated applications | IHC-P (FAQ Protocol) |
| Species reactivity | Reacts with: Mouse |
| Specificity | Mouse ADAMTS4 |
| Immunogen | A synthetic peptide corresponding to the center region of the Mouse ADAMTS4 |
| Preparation | Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Mouse ADAMTS4, and purified by antigen affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-ADAM-TS4 Antibody; Anti-ADAMTS-2 Antibody; Anti-Adamts4 Antibody; Anti-ADMP-1 Antibody
Image / Experimental Information
| Image 1 Description | Immunochemical staining of mouse ADAMTS4 in mouse kidney with rabbit polyclonal antibody at 1:500 dilution, formalin-fixed paraffin embedded sections. |
| Image 1 Alt Text | Mouse ADAMTS4 Immunohistochemistry(IHC) 19283 |
| Image 1 URL | Source image |
Background Information
| Full Name | ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
| Description | ADAMTSs (A disintegrin and metalloprotease domains with thrombospondins motifs) are a family of extracellular proteases that have been related to both oncogenic and tumor-suppressive functions. The ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) enzyme is a matrix-associated zinc metalloendopeptidase that plays an essential role in the degradation of cartilage aggrecan in arthritic diseases and has been recognized as one of the most primary targets for therapeutic intervention in osteoarthritis (OA). ADAMTS4 knockdown had no inhibitory implications on cell proliferation and invasion in vitro, but significantly attenuated tumor growth in vivo. Mechanistically, we revealed that ADAMTS4 was associated macrophages infiltration and polarization in the tumor microenvironment of CRC. Macrophage depletion largely abolished the promotive effect of ADAMTS4 on tumor growth in the immune competent BALB/c mice. CONCLUSION: ADAMTS4 seemed to be a promising prognostic indicator in CRC. The novel link between ADAMTS4 and macrophages mirrors the potential regulatory roles of ADAMTSs in the inflammatory microenvironment of cancers. Host-derived ADAMTS4 was expressed at the tumor vessels and was associated with early-stage tumor growth. ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) is a pathogenic factor of plaque vulnerability in mice. ADAMTS4 may be a potential biomarker for plaque vulnerability. |
-HD11DE1947-500-mouse-kidney-IHC-P.png){kind=link}